bf/NASDAQ:CYCN_icon.png

NASDAQ:CYCN

Cyclerion Therapeutics, Inc.

  • Stock

USD

Last Close

2.83

24/09 20:00

Market Cap

10.33M

Beta: 1.94

Volume Today

18

Avg: 293.75K

PE Ratio

−0.66

PFCF: −0.26

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
4.51M
-
2.30M
49.06%
3.32M
44.60%
297K
91.05%
cost of revenue
2.17M
-
472K
-
65K
86.23%
gross profit
-2.17M
-
4.51M
-
2.30M
49.06%
2.85M
24.04%
232K
91.85%
selling and marketing expenses
general and administrative expenses
15.12M
-
27.54M
82.13%
34.40M
24.94%
28.82M
16.24%
20.62M
28.44%
14.50M
29.66%
8.13M
43.93%
selling general and administrative expenses
10.48M
-
15.12M
44.31%
27.54M
82.13%
34.40M
24.94%
28.82M
16.24%
20.62M
28.44%
14.50M
29.66%
8.13M
43.93%
research and development expenses
50.90M
-
78.80M
54.81%
87.72M
11.31%
95.14M
8.46%
56.41M
40.70%
37.64M
33.29%
31.49M
16.32%
1.51M
95.19%
other expenses
-622K
-
-1.33M
113.50%
cost and expenses
63.55M
-
93.92M
47.78%
115.25M
22.71%
129.54M
12.40%
85.23M
34.21%
57.63M
32.38%
44.67M
22.50%
9.65M
78.40%
operating expenses
61.38M
-
93.92M
53.02%
115.25M
22.71%
129.54M
12.40%
85.23M
34.21%
57.63M
32.38%
44.67M
22.50%
9.65M
78.40%
interest expense
16K
-
294K
1,737.50%
ebitda
-61.38M
-
-92.18M
50.17%
-113.72M
23.38%
-122.34M
7.57%
-85.18M
30.37%
-53.84M
36.79%
-44.31M
17.71%
-9.65M
78.23%
operating income
-63.55M
-
-93.92M
47.78%
-115.25M
22.71%
-125.04M
8.49%
-81.27M
35.01%
-55.20M
32.08%
-44.37M
19.61%
-9.65M
78.26%
depreciation and amortization
2.17M
-
1.75M
19.73%
1.53M
12.44%
2.70M
76.70%
-3.92M
245.04%
1.35M
134.55%
65K
95.20%
total other income expenses net
2.03M
-
3.46M
70.68%
3.55M
2.45%
294K
91.71%
-2.95M
1,102.04%
income before tax
-63.55M
-
-93.92M
47.78%
-115.25M
22.71%
-123.01M
6.73%
-77.80M
36.75%
-51.65M
33.62%
-44.08M
14.66%
-12.59M
71.43%
income tax expense
-2.03M
-
-5.13M
152.93%
16K
100.31%
-294K
1,937.50%
8.42M
2,964.63%
net income
-63.55M
-
-93.92M
47.78%
-115.25M
22.71%
-120.98M
4.97%
-72.67M
39.93%
-51.66M
28.91%
-43.78M
15.25%
-21.02M
52.00%
weighted average shs out
1.37M
-
1.37M
0.36%
1.37M
0.00%
1.37M
0.28%
1.52M
11.04%
1.96M
28.75%
2.17M
11.03%
2.34M
7.59%
weighted average shs out dil
1.37M
-
1.37M
0.36%
1.37M
0.00%
1.37M
0.28%
1.52M
11.04%
1.96M
28.75%
2.17M
11.03%
2.34M
7.59%
eps
-46.39
-
-68.80
48.31%
-84.42
22.70%
-88.37
4.68%
-47.80
45.91%
-26.40
44.77%
-20.15
23.67%
-8.99
55.38%
epsdiluted
-46.39
-
-68.80
48.31%
-84.42
22.70%
-88.37
4.68%
-47.80
45.91%
-26.40
44.77%
-20.15
23.67%
-8.99
55.38%

All numbers in USD (except ratios and percentages)